Epidemiology

You have full text access to this OnlineOpen article

Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition

  1. Konstantinos K. Tsilidis1,†,*,
  2. Naomi E. Allen1,
  3. Timothy J. Key1,
  4. Miguel A. SanJoaquin2,
  5. Kjersti Bakken3,
  6. Franco Berrino4,
  7. Agnès Fournier5,6,7,
  8. Eiliv Lund3,
  9. Kim Overvad8,
  10. Anja Olsen9,
  11. Anne Tjønneland9,
  12. Graham Byrnes10,
  13. Veronique Chajes10,
  14. Sabina Rinaldi10,
  15. Marie-Christine Boutron-Ruault5,6,7,
  16. Francoise Clavel-Chapelon5,6,7,
  17. Jenny Chang-Claude11,
  18. Rudolf Kaaks11,
  19. Manuela Bergmann12,
  20. Heiner Boeing12,
  21. Yvoni Koumantaki13,
  22. Domenico Palli14,
  23. Valeria Pala4,
  24. Salvatore Panico15,
  25. Rosario Tumino16,
  26. Paolo Vineis17,18,
  27. H. Bas Bueno-de-Mesquita19,
  28. Fränzel J.B. van Duijnhoven19,
  29. Carla H. van Gils20,
  30. Petra H.M. Peeters20,
  31. Laudina Rodríguez21,
  32. Carlos A. González22,
  33. María-José Sánchez23,
  34. Maria-Dolores Chirlaque24,
  35. Aurelio Barricarte25,
  36. Miren Dorronsoro26,
  37. Kay-Tee Khaw27,
  38. Sheila A. Rodwell28,‡,
  39. Teresa Norat18,
  40. Dora Romaguera18,
  41. Elio Riboli18

Article first published online: 9 JUN 2010

DOI: 10.1002/ijc.25504

Issue

International Journal of Cancer

International Journal of Cancer

Volume 128, Issue 8, pages 1881–1889, 15 April 2011

Additional Information

How to Cite

Tsilidis, K. K., Allen, N. E., Key, T. J., SanJoaquin, M. A., Bakken, K., Berrino, F., Fournier, A., Lund, E., Overvad, K., Olsen, A., Tjønneland, A., Byrnes, G., Chajes, V., Rinaldi, S., Boutron-Ruault, M.-C., Clavel-Chapelon, F., Chang-Claude, J., Kaaks, R., Bergmann, M., Boeing, H., Koumantaki, Y., Palli, D., Pala, V., Panico, S., Tumino, R., Vineis, P., Bas Bueno-de-Mesquita, H., van Duijnhoven, F. J.B., van Gils, C. H., Peeters, P. H.M., Rodríguez, L., González, C. A., Sánchez, M.-J., Chirlaque, M.-D., Barricarte, A., Dorronsoro, M., Khaw, K.-T., Rodwell, S. A., Norat, T., Romaguera, D. and Riboli, E. (2011), Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer, 128: 1881–1889. doi: 10.1002/ijc.25504

Author Information

  1. 1

    Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom

  2. 2

    Malawi-Liverpool-Wellcome Trust, Clinical Research Programme, Blantyre, Malawi

  3. 3

    Department of Community Medicine, University of Tromsø, Tromsø, Norway

  4. 4

    Department of Preventive and Predictive Medicine, National Cancer Institute, Milan, Italy

  5. 5

    INSERM (Institut National de la Santé et de la Recherche Médicale), ERI 20, Villejuif, France

  6. 6

    University Paris-South 11, EA 4045, IFR69, Villejuif, France

  7. 7

    Institut Gustave Roussy, Villejuif, France

  8. 8

    Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark

  9. 9

    Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark

  10. 10

    International Agency for Research on Cancer, Lyon, France

  11. 11

    Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany

  12. 12

    Department of Epidemiology, German Institute of Human Nutrition, Potsdam, Germany

  13. 13

    Department of Hygiene and Epidemiology, University of Athens Medical School, Athens, Greece

  14. 14

    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy

  15. 15

    Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy

  16. 16

    Cancer Registry and Histopathology Unit, Department of Oncology, Azienda Ospedaliera “Civile – M.P.Arezzo”, Ragusa, Italy

  17. 17

    ISI Foundation, Torino, Italy

  18. 18

    Department of Epidemiology and Public Health, Imperial College, London, United Kingdom

  19. 19

    National Institute for Public Health and the Environment, Centre for Nutrition and Health, Bilthoven, The Netherlands

  20. 20

    Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands

  21. 21

    Public Health and Participation Directorate, Health and Health Care Services Council, Asturias, Spain

  22. 22

    Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Barcelona, Spain

  23. 23

    Andalusian School of Public Health and CIBER de Epidemiología y Salud Pública, Granada, Spain

  24. 24

    Department of Epidemiology, Regional Health Authority and CIBER de Epidemiología y Salud Pública, Murcia, Spain

  25. 25

    Public Health Institute of Navarra, Pamplona, Spain

  26. 26

    Public Health Division of Gipuzkoa and CIBER de Epidemiología y Salud Pública, San Sebastian, Spain

  27. 27

    Clinical Gerontology Unit, University of Cambridge, Cambridge, United Kingdom

  28. 28

    Medical Research Council Dunn Human Nutrition Unit, University of Cambridge, Cambridge, United Kingdom

  1. †

    Tel.: +44-(0)-1865-289647, Fax: +44-(0)-1865-289610

  2. ‡

    Deceased

*Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford OX3 7LF, United Kingdom

Publication History

  1. Issue published online: 22 FEB 2011
  2. Article first published online: 9 JUN 2010
  3. Manuscript Accepted: 17 MAY 2010
  4. Manuscript Received: 10 MAR 2010

Funded by

  • Europe Against Cancer Program of the European Commission (SANCO)
  • Danish Cancer Society
  • Ligue Nationale contre le Cancer, 3M Company, Institut National de la Santé
  • et de la Recherche Médicale
  • German Cancer Aid
  • German Cancer Research Centre
  • German Federal Ministry of Education and Research
  • Dutch Ministry of Public Health, Welfare, and Sports
  • National Cancer Registry and the Regional Cancer Registries Amsterdam, Dutch Ministry of Health
  • Dutch Prevention Funds
  • LK Research Funds
  • Dutch Zorg Onderzoek Nederland
  • East and Maastricht of the Netherlands
  • Norwegian Cancer Society
  • Norwegian Research Council
  • Greek Ministry of Health and Social Solidarity
  • Hellenic Health Foundation
  • Stavros Niarchos Foundation
  • Italian Association for Research on Cancer
  • Italian National Research Council
  • Health Research Fund (FIS)
  • of the Spanish Ministry of Health
  • Spanish Regional Governments of Andalusia, Asturias, Basque Country, Murcia and Navarra and ISCIII
  • Swedish Cancer Society
  • Swedish Scientific Council
  • Regional Government of Skane, Sweden
  • Cancer Research UK
  • Medical Research Council, United Kingdom
  • Stroke Association, United Kingdom
  • British Heart Foundation
  • Department of Health, United Kingdom
  • Food Standards Agency, United Kingdom, Wellcome Trust, World Cancer Research Fund, United Kingdom, U.S. Army Medical Research and Material Command. Grant Number: DAMD 17-01-0275
  • U.S. National Cancer Institute. Grant Number: U01 CA098216-01

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (303K)

References

  • 1
    Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106: 574–82.
  • 2
    Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998; 7: 653–9.
  • 3
    Nanda K, Bastian LA, Hasselblad V, Simel DL. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 1999; 93: 880–8.
  • 4
    Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004; 350: 991–1004.
  • 5
    Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, et al. Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative Randomized Clinical Trial. Cancer Epidemiol Biomarkers Prev 2008; 17: 2609–18.
  • 6
    Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR. Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control 2007; 18: 723–33.
  • 7
    Csizmadi I, Collet JP, Benedetti A, Boivin JF, Hanley JA. Defining hormone replacement therapy in longitudinal studies: impact on measures of effect. Pharmacoepidemiol Drug Saf 2004; 13: 215–25.
    Direct Link:
  • 8
    Delellis Henderson K, Duan L, Sullivan-Halley J, Ma H, Clarke CA, Neuhausen SL, Templeman C, Bernstein L. Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. Am J Epidemiol 171: 415–25.
  • 9
    Dinger JC, Heinemann LA, Mohner S, Thai do M, Assmann A. Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer 2007; 7: 76.
  • 10
    Hildebrand JS, Jacobs EJ, Campbell PT, McCullough ML, Teras LR, Thun MJ, Gapstur SM. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II. Cancer Epidemiol Biomarkers Prev 2009; 18: 2835–41.
  • 11
    Hoffmeister M, Raum E, Krtschil A, Chang-Claude J, Brenner H. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clin Pharmacol Ther 2009; 86: 416–24.
  • 12
    Johnson JR, Lacey JV, Jr, Lazovich D, Geller MA, Schairer C, Schatzkin A, Flood A. Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 196–203.
  • 13
    Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 1995; 87: 1067–71.
  • 14
    Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter JD. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 2007; 67: 7534–9.
  • 15
    Prentice RL, Pettinger M, Beresford SA, Wactawski-Wende J, Hubbell FA, Stefanick ML, Chlebowski RT. Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative Clinical Trial and Observational Study. Cancer Epidemiol Biomarkers Prev 2009; 18: 1531–7.
  • 16
    Prihartono N, Palmer JR, Louik C, Shapiro S, Rosenberg L. A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 443–7.
  • 17
    Rennert G, Rennert HS, Pinchev M, Lavie O, Gruber SB. Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol 2009; 27: 4542–7.
  • 18
    Tannen RL, Weiner MG, Xie D, Barnhart K. Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy. Hum Reprod 2007; 22: 1769–77.
  • 19
    Tannen RL, Weiner MG, Xie D, Barnhart K. A simulation using data from a primary care practice database closely replicated the women's health initiative trial. J Clin Epidemiol 2007; 60: 686–95.
  • 20
    Wu AH, Siegmund KD, Long TI, Cozen W, Wan P, Tseng CC, Shibata D, Laird PW. Hormone therapy, DNA methlyation and colon cancer. Carcinogenesis 2010; 31: 1060–7.
  • 21
    Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113–24.
  • 22
    Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Fournier A, Chabbert-Buffet N, Boeing H, et al. Reproductive risk factors and endometrial cancer: the european prospective investigation into cancer and nutrition. Int J Cancer 2010; 127: 442–51.
  • 23
    World Health Organization Collaborating Centre for Drug Statistics Methodology NIoPH. The Anatomical Therapeutic Chemical Classification System. Available at: http://www.whocc.no/atc_ddd_index/, 2010.
  • 24
    Stanczyk FZ. All progestins are not created equal. Steroids 2003; 68: 879–90.
  • 25
    Ferrari P, Jenab M, Norat T, Moskal A, Slimani N, Olsen A, Tjonneland A, Overvad K, Jensen MK, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2007; 121: 2065–72.
    Direct Link:
  • 26
    Friedenreich C, Norat T, Steindorf K, Boutron-Ruault MC, Pischon T, Mazuir M, Clavel-Chapelon F, Linseisen J, Boeing H, Bergman M, Johnsen NF, Tjonneland A, et al. Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006; 15: 2398–407.
  • 27
    Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjonneland A, Halkjaer J, Jensen MK, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105–20.
  • 28
    Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69: 239–41.
  • 29
    Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101–29.
  • 30
    Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288: 58–66.
  • 31
    McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980; 65: 1201–7.
  • 32
    Campagnoli C, Biglia N, Altare F, Lanza MG, Lesca L, Cantamessa C, Peris C, Fiorucci GC, Sismondi P. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol 1993; 7: 251–8.
  • 33
    Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536–40.
  • 34
    Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas 2003; 46( Suppl 1): S7–S16.
  • 35
    Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005; 294: 914–23.
  • 36
    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33.
View Full Article (HTML) Get PDF (303K)